Bone Marrow Failure Syndromes

Bone Marrow Failure Syndromes

  • Overview
  • Approach
  • Appointments
  • Diagnosis
  • Treatment
  • Locations
  • Doctors

    • What are bone marrow failure syndromes?

    There are three main types of blood cells in the body: 

    • White blood cells, which work to ward off and fight infection
    • Red blood cells, which contain hemoglobin, carry iron and deliver oxygen to tissues throughout the body
    • Platelets, which help form clots and stop bleeding

    All these cells and their precursors are produced in bone marrow before maturing and being released into the blood stream. The bone marrow is located in the long bones of the body, namely the hips, upper leg and sternum. When the blood cells are not made in sufficient quantities or are abnormal, a Bone Marrow Failure Syndrome (BMFS) can result. Low peripheral blood counts can indicate a bone marrow failure.

    Bone marrow failure syndromes may be present at birth or develop later in life. Some bone marrow failure syndromes are due to an underlying inherited genetic condition, while other bone marrow failure syndromes are due to an acquired cause such as viral or drug/toxin exposures. In many cases of bone marrow failure, the underlying cause cannot be identified and the term “idiopathic” is used. The bone marrow failure can manifest as one isolated cytopenia (one blood cell type decreased) or pancytopenia (all three blood cell types decreased).

    Our Approach

    Bone marrow failure patients at C.S. Mott Children’s Hospital benefit from a team-based approach to care with access to medical experts within hematology/oncology, genetics, bone marrow transplantation, infectious disease, rheumatology and allergy/immunology. 

    Our team has extensive research efforts in bone marrow failure syndromes and are actively involved in international efforts to better understand and treat these illnesses. This work includes clinical trials which focus on the management of care and improvement of quality of life for patients, and membership in the North American Pediatric Aplastic Anemia Consortium (NAPAAC).

    Mott pediatric hematologists are recognized nationally as experts within the field with many having published peer-reviewed articles and received funding awards related to bone marrow failure syndromes. All these efforts help bring the latest and greatest care to our patients.

    Among the bone marrow failure conditions we care for here at U-M Health are:

    • Amegakaryocytic thrombocytopenia
    • Aplastic anemia, idiopathic or post-infectious
    • Diamond blackfan anemia
    • Deficiency of ADA2 (DADA2)
    • Dyskeratosis congenita
    • Fanconi anemia
    • MIRAGE syndrome
    • Paroxysmal nocturnal hemoglobinuria (PNH)
    • Pearson syndrome
    • Shwachman diamond syndrome
    • Thrombocytopenia with absent radii

    Appointment Information

    For more information regarding the Immuno-Hematology Comprehensive Program, or to schedule an appointment, please call 734-936-9814.

    How are BMFS diagnosed?

    Correct diagnosis of Bone Marrow Failure Syndromes (BMFS) is important because the management and treatment of inherited syndromes differ from those of acquired syndromes. Each condition requires unique care and greatly benefits from a multidisciplinary care team of specialists. 

    In cases of inherited bone marrow failure syndromes, rapid diagnosis of the condition facilitates focused disease surveillance, proper anticipatory guidance and minimization of disease- and treatment-related complications for the patient and potentially affected family members.

    How are BMFS treated?

    Treatment of bone marrow failure is heavily dependent on the underlying cause of the bone marrow failure, but can include careful monitoring of blood counts and supportive care, immunosuppression and/or bone marrow transplant.

    Locations
    • Pediatric Hematology Clinic | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 7 Reception C
      Ann Arbor, MI 48109-4257       Get Directions

    Doctors

     Search for a U-M Health doctor     Thomas Frank Michniacki, MD

    Thomas Frank Michniacki, MD

    Clinical Associate Professor

    Pediatric Hematology-Oncology, Pediatrics

    Mark Thomas Vander Lugt, MD

    Mark Thomas Vander Lugt, MD

    Clinical Associate Professor

    Pediatric Hematology-Oncology, Pediatrics

    News & Stories
    Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
    Philanthropy News

    A pediatric epilepsy fundraiser that changes lives

    Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
         red blood cells going through clear tube red background
    Health Lab

    FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

    FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.
         Headshot of Abel, a smiling toddler wearing a headband with two gold pompoms.
    Philanthropy News

    Block Out Cancer: From a crisis abroad to answers at Mott

    Your gift to Block Out Cancer helps children like Abel overcome childhood cancer. Donations fill critical gaps for lifesaving pediatric cancer research and care at C.S. Mott Children's Hospital.
         baby with hearing aid on ear looking from side view with blue pacifier in mouth
    Health Lab

    Research may help better predict outcomes in kids with congenital cytomegalovirus

    Two new studies may help researchers and clinicians better understand congenital cytomegalovirus (CMV), the most common infectious cause of birth defects and a leading cause of non-genetic hearing loss in children.
         family smiling inside capitol
    Health Lab

    12-year-old shares journey with sickle cell anemia on Capitol Hill

    A 12-year-old takes his story to Washington, D.C., sharing with lawmakers how specialized treatment transformed his life with sickle cell disease.
         little boy with basketballs and Michigan C.S. Mott logo behind him
    Health Lab

    First U-M patient receives newly FDA-approved stem cell therapy for sickle cell anemia

    Elijah Dottery, diagnosed with sickle cell anemia as a baby, becomes the first U-M patient to receive the newly-approved FDA therapy which involves using mesenchymal stem cells.